Division of Research, Kaiser Permanente Northern California, Oakland, CA.
Pharmacovigilance, Bayer US, Whippany, NJ.
Invest Radiol. 2019 May;54(5):296-301. doi: 10.1097/RLI.0000000000000541.
Although it is generally acknowledged that exposure to iodine contrast agents can interfere with thyroid function, little is known about the incidence of iodine-induced hypothyroidism in young children (younger than the age of 4 years).
This was a retrospective cohort study to estimate the incidence rate of detected hypothyroidism in a US-based general population of pediatric patients exposed to an iodinated contrast agent.
The study was conducted in Kaiser Permanente Northern California, an integrated health care delivery system.
This study included 2320 pediatric patients younger than 4 years of age who had a diagnostic procedure with an iodinated contrast agent during years 2008 to 2016.
Among 2320 young children who met our study criteria, we identified 34 who met the initial criteria to be a case of hypothyroidism. The incidence density ratio for all hypothyroidism in iodine contrast agent-exposed patients was 1.33 per 1000 person months (95% confidence interval, 0.9-1.8). Most cases appeared to have subclinical hypothyroidism. The rate was higher for the probably iodine-induced cases (0.90 per 1000 person months) compared with cases with a possible alternate etiology (0.43 per 1000 person months), for males compared with females, and among children who had a heart catheterization compared with those with a computed tomography scan. It was also highest among the youngest children (younger than 3 months old), and decreased with increasing age.
Our finding of hypothyroidism in young children exposed to iodine contrast agents (1.33 per 1000 person months [95% confidence interval, 0.9-1.8]) is broadly consistent with the sparse literature on this outcome.
尽管人们普遍认为碘造影剂的暴露会干扰甲状腺功能,但对于年龄在 4 岁以下的幼儿中碘诱发甲状腺功能减退症的发生率知之甚少。
本研究采用回顾性队列研究,旨在评估美国儿童人群中接触碘造影剂后甲状腺功能减退症的检出率。
本研究在 Kaiser Permanente Northern California 进行,这是一个综合性医疗服务系统。
这项研究纳入了 2008 年至 2016 年间在接受碘造影剂诊断性检查的 2320 名年龄小于 4 岁的儿科患者。
在符合本研究标准的 2320 名幼儿中,我们确定了 34 名符合初始甲状腺功能减退症病例标准的患者。碘造影剂暴露患者所有甲状腺功能减退症的发生率密度比为 1.33/1000 人月(95%置信区间,0.9-1.8)。大多数病例似乎为亚临床甲状腺功能减退症。碘可能诱发的病例的发生率(0.90/1000 人月)高于可能存在其他病因的病例(0.43/1000 人月),男性高于女性,行心导管术的儿童高于行计算机断层扫描的儿童。在年龄最小的儿童(小于 3 个月)中发生率最高,且随年龄增长而降低。
本研究发现,接触碘造影剂的幼儿中存在甲状腺功能减退症(1.33/1000 人月[95%置信区间,0.9-1.8]),这与该结局的文献资料很少的情况基本一致。